Cite
HARVARD Citation
Gjini, E. et al. (n.d.). 733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy. Journal for immunotherapy of cancer. p. A777. [Online].